Joseph Truitt Larimar Therapeutics, Inc. (LRMR) insider trading activity
Joseph Truitt is Director of Larimar Therapeutics, Inc.. Currently has a direct ownership of 2,750 shares of LRMR, which is worth approximately $17,132. The most recent transaction as insider was on May 17, 2023, when has been sold 2,750 shares (Common Stock) at a price of $3.73 per share, resulting in proceeds of $10,257. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.75K
0%
3M change
0%
12M change
Total Value Held
$17,132
JT
Joseph Truitt
Director
Bala Cynwyd, PA